A receptor-grounded approach to teaching nonsteroidal antiinflammatory drug chemistry and structure-activity relationships

American Journal of Pharmaceutical Education

Volumn 73, Issue 8, 2009, Pages

  Roche, Victoria F ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Medicinal chemistry; Nonsteroidal antiinflammatory drugs

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CLINICAL COMPETENCE; COMPREHENSION; EDUCATION; HEALTH CARE QUALITY; HUMAN; METABOLISM; METHODOLOGY; PROBLEM BASED LEARNING; PROGRAM DEVELOPMENT; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; TEACHING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING SITES; CHEMISTRY, PHARMACEUTICAL; CLINICAL COMPETENCE; COMPREHENSION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; EDUCATION, PHARMACY; EDUCATIONAL MEASUREMENT; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROBLEM-BASED LEARNING; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; TEACHING;

EID: 74749094736     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/aj7308143     Document Type: Article

References (22)

1. Vane JR, Bakhle S, Botting RM. Cyclooxygenase 1 and 2. Ann Rev Pharmacol Toxicol. 1998;38(April):97-120.
2. Chubb AJ, Fitzgerald DJ, Nolan KB, Moman E. The productive conformation of prostaglandin G2 at peroxidase site of prostaglandin endoperoide H synthase: docking, molecular dynamics, and site-directed mutagenesis studies. Biochemistry. 2006;45(3):811-820.
3. Roche VF. The chemically elegant proton pump inhibitors: A self-contained, clinically relevant medicinal chemistry lesson. Am J Pharm Educ. 2006;70(5):Article 101.
4. Roche VF. Antihyperlipidemic statins: a self-contained, clinically relevant medicinal chemistry lesson. Am J Pharm Educ. 2005; 69(4):Article 77.
5. Thuresson ED, Lakkides KM, Rieke CJ, et al. Prostaglandin endoperoxide H synthase-1. J Biol Chem. 2001;276(13):10347-10359.
6. Furse KE, Pratt DA, Porter NA, Lybrand TP. Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior. Biochemistry. 2006;45(10): 3198-3205.
7. Palomer A, Perez JJ, Navea S, Llorens O, Pascual J, Garcia L, Mauleon D. Modeling cyclooxygenase inhibition: implication of active site hydration on the selectivity of ketoprofen analogues. J Med Chem. 2000;43(11):2280-2284.
8. Kiefer JR, Pawlitz JL, Moreland KT, et al. Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature. 2000;405:97-101.
9. Rowlinson SW, Crews BC, Goodwin DC, Schneider C, Gierse JK, Marnett LJ. Spatial requirements for 15-(R)-hydroxy-5Z-8Z-11Z-13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. Why acetylated COX-1 does not synthesize 15-(R)-HETE. J Biol Chem. 2000;275(9):6586- 6591.
10. Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384(6610):644-648.
11. Anana R, Rap PNP, Chen Q-H, Knaus EE. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors. Bioorganic Med Chem. 2006;14:5259-5265.
12. Riendeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0662):Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exper Ther. 2001;296(2):558-566.
13. Borne R, Levi M, Wilson N. Nonsteroidal anti-inflammatory drugs. In: Williams DA, Lemke TL, eds. Foye's Principles of Medicinal Chemistry, 6th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2008:970.
14. Harman CA, Turman MV, Kozak KR, et al. Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides. J Biol Chem. 2007; 282:28096-28105.
15. Rowlinson SW, Kiefer JR, Prusakiewicz JJ, et al. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem. 2003;278:45763-45769.
16. RCSB Protein Data Bank. http://www.rcsb.org/pdb/static.do?p=search/index. html. Accessed September 8, 2009.
17. Postmarket Drug Safety Information for Patients and Providers. Food and Drug Administration Web site. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/default.htm Accessed November 24, 2009.
18. Vane JR, Gotting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(3A):2S-8S.
19. Prusakiewicz JJ, Felts AS, Mackenzie BS, Marnett LJ. Molecular basis of the time-dependent inhibition of cyclooxygenase by indomethacin. Biochemistry. 2005;43: 15439-15445.
20. Takakusa H, Masumoto H, Mitsuru A, Okazaki O, Sudo K. Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes. Drug Metab Dispos. 2008; 36(5):816-823.
21. Roche VF. Improving pharmacy students' understanding and long-term retention of acid-base chemistry. Am J Pharm Educ. 2007;71(6):Article 122.
22. Roche VF, Zito SW. Development and evaluation of a new computerized medicinal chemistry case study on NSAID chemistry and therapeutics: the Drugfather [abstract]. Meeting Abstracts. 109th Annual Meeting of the American Association of Colleges of Pharmacy, Chicago, Illinois, July 19-23, 2008. Am J Pharm Educ. 2008; 72(3):Article 72.